根据最终合并协议,Viewpoint的每一股已发行和流通股份将转换为获得Isoray 3.3212股的权利。Viewpoint股东将拥有Isoray完全稀释的流通股49%的股份。
$华海药业(SH600521)$ $华东医药(SZ000963...查看全文
$Isoray(ISR)$ 8-K Current report, items 1.01, 1.02, 5.02, and 9.01 Accession Number: 0001437749-21-013733 Act: 34 Size: 109 KB 网页链接
$Isoray(ISR)$ SD Specialized disclosure report Accession Number: 0001437749-21-013548 Act: 34 Size: 17 KB 网页链接
$Isoray(ISR)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001437749-21-012716 Act: 33 Size: 836 KB 网页链接
$Isoray(ISR)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001437749-21-012141 Act: 34 Size: 3 MB 网页链接
$Isoray(ISR)$ 8-K Current report, items 2.02, 8.01, and 9.01 Accession Number: 0001437749-21-012055 Act: 34 Size: 178 KB 网页链接
$Isoray(ISR)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0001437749-21-006903 Act: 34 Size: 90 KB 网页链接
$Isoray(ISR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-21-006164 Size: 23 KB 网页链接
$Isoray(ISR)$ 8-K Current report, item 5.02 Accession Number: 0001437749-21-005148 Act: 34 Size: 19 KB 网页链接
$Isoray(ISR)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0001437749-21-002804 Act: 34 Size: 26 KB 网页链接
$Isoray(ISR)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001437749-21-002638 Act: 33 Size: 761 KB 网页链接